Tecentriq
Combination therapy for hepatocellular carcinoma
Combination therapy for unresectable or metastatic melanoma
Combination therapy for unresectable locally advanced or metastatic triple-negative breast cancer
Combination therapy for small cell lung cancer
Monotherapy for locally advanced or metastatic non-small cell lung cancer
Monotherapy for locally advanced or metastatic urothelial cancer
Active ingredient: atezolumab
Storage temperature 4-8 degrees
Prescription drug.
Дозировка | 840 Mg, 1200 Mg |
---|